After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Iovance Biotherapeutics Inc is $1.90B. A total of 5.99 million shares were traded on the day, compared to an average of 7.86M shares.
In the most recent transaction, Maynard Ryan D sold 50,000 shares of IOVA for 10.06 per share on Nov 12 ’24. After the transaction, the Director now owns 7,500 company shares. In a previous transaction on Nov 12 ’24, Maynard Ryan D bought 50,000 shares at 10.06 per share.
Among the insiders who bought shares, MCPEAK MERRILL A acquired of 250,000 shares on Feb 20 ’24 at a per-share price of $9.15. This resulted in the Director holding 320,150 shares of IOVA after the transaction. In another insider transaction, Dukes Iain D. bought 32,000 shares at $9.15 per share on Feb 20 ’24. Company shares held by the Director now total 54,000.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, IOVA has a high of $18.33 and a low of $5.57.
As of this writing, IOVA has an earnings estimate of -$0.27 per share for the current quarter. EPS was calculated based on a consensus of 11.0 estimates, with a high estimate of -$0.23 per share and a lower estimate of -$0.36.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. IOVA’s latest balance sheet shows that the firm has $504.41M in Cash & Short Term Investments as of fiscal 2021. There were $71.53M in debt and $89.20M in liabilities at the time. Its Book Value Per Share was $2.54, while its Total Shareholder’s Equity was $621.66M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IOVA is Buy with a score of 4.73.
